|
Section sizes
|
Section size for Variants of SARS-CoV-2 (67 sections)
Section name |
Byte count |
Section total
|
(Top) |
2,871 |
2,871
|
Overview |
27,225 |
27,225
|
Nomenclature |
10,995 |
18,722
|
Lineages and clades |
5,651 |
5,651
|
Classification of variants |
2,076 |
2,076
|
Reference sequence |
5,327 |
5,327
|
Notability criteria |
3,215 |
3,215
|
Variants of concern (WHO) |
821 |
13,595
|
Omicron |
51 |
12,774
|
Lineage B.1.1.529 |
4,022 |
4,022
|
BA. sublineages |
2,018 |
2,018
|
Further sublineages emerging in 2022 |
1,338 |
1,338
|
Further sublineages emerging in 2023: EG.5 "Eris", BA.2.86, and JN.1 "Pirola" |
5,345 |
5,345
|
Variant of concern lineages under monitoring (WHO) |
2,078 |
2,078
|
Variants of interest (WHO) |
1,945 |
1,945
|
Variants under monitoring (WHO) |
568 |
568
|
Previously circulating and formerly monitored variants (WHO) |
474 |
76,256
|
Previously circulating variants of concern (VOC) |
299 |
46,531
|
Alpha (lineage B.1.1.7) |
10,889 |
14,229
|
B.1.1.7 with E484K |
3,340 |
3,340
|
Beta (lineage B.1.351) |
6,343 |
6,343
|
Gamma (lineage P.1) |
13,230 |
13,230
|
Delta (lineage B.1.617.2) |
12,430 |
12,430
|
Previously circulating variants of interest (VOI) |
1,055 |
27,621
|
Epsilon (lineages B.1.429, B.1.427, CAL.20C) |
10,334 |
10,334
|
Zeta (lineage P.2) |
620 |
620
|
Eta (lineage B.1.525) |
4,359 |
4,359
|
Theta (lineage P.3) |
4,585 |
4,585
|
Iota (lineage B.1.526) |
924 |
924
|
Kappa (lineage B.1.617.1) |
2,160 |
2,160
|
Lambda (lineage C.37) |
2,114 |
2,114
|
Mu (lineage B.1.621) |
1,470 |
1,470
|
Formerly monitored variants (WHO) |
1,630 |
1,630
|
Other notable variants |
15,175 |
15,175
|
Notable missense mutations |
109 |
38,550
|
del 69-70 |
708 |
708
|
RSYLTPGD246-253N |
2,409 |
2,409
|
N440K |
1,929 |
1,929
|
G446V |
1,168 |
1,168
|
L452R |
780 |
780
|
Y453F |
765 |
765
|
S477G/N |
2,469 |
2,469
|
E484Q |
1,278 |
1,278
|
E484K |
5,806 |
5,806
|
F490S |
1,443 |
1,443
|
N501Y |
2,624 |
2,624
|
N501S |
1,687 |
1,687
|
D614G |
5,847 |
5,847
|
Q677P/H |
2,209 |
2,209
|
P681H |
2,062 |
2,062
|
P681R |
505 |
505
|
A701V |
4,752 |
4,752
|
Recombinant variants |
1,519 |
1,519
|
Differential vaccine effectiveness |
2,299 |
2,475
|
Immune evasion by variants |
89 |
176
|
Vaccine adjustments |
87 |
87
|
Data and methods |
2,319 |
8,960
|
New variant detection and assessment |
3,960 |
3,960
|
Testing |
2,681 |
2,681
|
Incubation theory for multiple mutated variants |
2,023 |
2,023
|
Cross-species transmission |
2,089 |
6,390
|
Cluster 5 |
4,301 |
4,301
|
See also |
361 |
361
|
Notes |
517 |
517
|
References |
4,173 |
4,173
|
Further reading |
1,026 |
1,026
|
External links |
440 |
440
|
Total |
233,411 |
233,411
|
| |